2007's Information

2007/12/21

Phase I Human Trial of F351 Initiated in China

2007/12/21

GNI Announces Management Change

2007/12/19

GNI Scientists Discovered New Regulatory Mechanism of Key Inflammatory Disease Signalling Pathway

2007/11/21

GNI Announces IND Approval in China for Novel Liver Disease Drug F351

2007/11/07

China Patent and Trademark Office Grants Patent for F351,GNI’s Key Therapeutic Product for Liver Disease

2007/11/07

China Patent and Trademark Office Grants Patent for F351, GNI’s Key Therapeutic Product for Liver Disease

2007/10/25

GNI Receives Patent Approval in China for Important Cancer Targets

2007/10/25

GNI Receives Patent Approval in China for Important Cancer Targets

2007/10/23

AusBiotech 2007

2007/10/17

GNI Researchers in China Identify Important New Regulator of Inflammation